Rare hemolytic anemia innovation creating infrastructure — pyruvate kinase deficiency treatments providing enzyme replacement managing hereditary hemolytic anemia enabling survival support, establishing PK treatment as essential rare disease infrastructure, with the Pyruvate Kinase Deficiency Market experiencing expansion driven by PK deficiency prevalence, hemolysis management demand,...